跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
APX-PRAVASTATIN pravastatin sodium 40 mg tablet blister pack
Approved
STANDARD
APX-PRAVASTATIN pravastatin sodium 40 mg tablet blister pack
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
69e9fa53d0a85078
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
69e9fa53d0a85078
Product Name
APX-PRAVASTATIN pravastatin sodium 40 mg tablet blister pack
Artg Id
335752
Artg Name
APX-PRAVASTATIN pravastatin sodium 40 mg tablet blister pack
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2020-06-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/9ce1824d0ce643da5d1ae0e41ea53d1f.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/b2d35b5d907f5f660200bbe4da0b4c4a.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
69e9fa53d0a85078
Type
Standard
Back to TGA Approvals
APX-PRAVASTATIN pravastatin sodium 40 mg tablet blister pack - TGA Drug Approval Details
